Annual Reports
Browse
Browsing Annual Reports by Subject "Cyclotrons"
Now showing 1 - 13 of 13
Results Per Page
Sort Options
- ItemAnnual report 2019 - 2020(Australian Nuclear Science and Technology Organisation, 2020-10-26) Australian Nuclear Science and Technology OrganisationANSTO leverages great science to deliver big outcomes. ● We partner with scientists and engineers and apply new technologies to provide real-world benefits. ● Our work improves human health, saves lives, builds our industries and protects the environment. ANSTO is the home of Australia’s most significant landmark and national infrastructure for research including the Open Pool Australian Light-water (OPAL) multi-purpose nuclear reactor, the Australian Synchrotron, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering (ACNS) and the National Deuteration Facility (NDF). Every year, thousands of scientists from industry and academia benefit from gaining access to these stateof-the-art facilities. As part of enabling a strong national collaborative network, ANSTO is connected with 40 Australian and New Zealand universities through the Australian Institute of Nuclear Science and Engineering (AINSE), providing researchers with access to Australia’s nuclear science, technology and engineering expertise and national infrastructure which, in turn, facilitates greater national science collaboration. ANSTO has nearly 50 bilateral international memoranda of understanding (MOU) agreements with worldleading research institutes and universities that ensure that Australian scientists are well placed to drive innovation for Australia. These important partnerships give Australian scientists access to some of the world’s most sophisticated research techniques, enabling discoveries that benefit both Australia and the world. ANSTO’s nuclear medicines benefit thousands of Australians every week, supporting the accurate diagnosis of heart disease, skeletal conditions and cancer. Australia has a strong international role in nuclear science and technology through ANSTO. As a member of the International Atomic Energy Agency (IAEA) Board of Governors, Australia is committed to the peaceful application of nuclear science and technology. ANSTO’s long-term partnership with the IAEA has given our country important global responsibilities and recognition. ANSTO has two main campuses at Lucas Heights in New South Wales and Clayton in Victoria. ANSTO also works from and operates a facility in Camperdown in New South Wales.
- ItemAnnual report 2020-2021(Australian Nuclear Science and Technology Organisation, 2021-10) Australian Nuclear Science and Technology OrganisationThis annual report provides a summary of our activities and performance for the financial year ending 30 June 2021 against the performance measures in our 2020–2021 Corporate Plan and Portfolio Budget Statements.
- ItemANSTO annual report 1999-00.(Australian Nuclear Science and Technology Organisation, 2000)The period from July 1999 to June 2000 has, yet again, been both exciting and challenging. Our most important project is the Replacement Research Reactor Project - important not only for the future of the Organisation but also for the maintenance and development of a range of scientific and technological expertise that will underpin Australia's socio-economic development in the knowledge era. In August 1999 this project received unanimous approval from the bipartisan Public Works Committee. ANSTO immediately released the Request for Tender to the four prequalified vendors. All vendors, in alliance or partnership with Australian engineering companies, submitted proposals on the closing date of January 3rd, 2000. These proposals were reviewed and evaluated by internal and external experts, culminating in the final recommendation that INVAP SE, in alliance with John Holland Construction and Engineering Pty Ltd and Evans Deakin Industries Limited, be awarded the contract for the detailed engineering design, construction and commissioning of the replacement research reactor at the Lucas Heights Science and Technology Centre. After obtaining all relevant approvals, the contract was signed early in July and marked by a ceremony involving many of the people who had contributed to the process. The tender selection process was audited from start to finish and the relevant audit and review reports posted on ANSTO's website as part of our community advice. As this Annual Report goes to press the project is well underway. ANSTO staff are to be commended for their professionalism and dedication throughout the replacement research reactor project to date. They have worked tirelessly and met all major milestones under their control. It was heartening to learn that our comprehensive and independently audited consultation program during the environmental assessment phase of the replacement research reactor project was acclaimed by two awards from the Public Relations Institute of Australia. All of us at ANSTO appreciate the very considerable support and encouragement we have received from government, individuals, companies and professional societies across the science, engineering, medical and policy spectra. We look forward to working with our stakeholders to ensure that the scientific instruments developed for the various beamlines on the reactor are capable of delivering world class outcomes. During the past year current ANSTO's core nuclear facilities have been in strong demand. Staff and students from universities across Australia have accessed the facilities through AINSE, there being around 160 AINSE-supported university projects in the past year. ANSTO staff not only facilitate the execution of these projects but also undertake research to underpin other important elements of ANSTO's mission. Such projects are frequently carried out in collaboration with national and international teaming partners.
- ItemANSTO annual report 2000-01(Australian Nuclear Science and Technology Organisation, 2001) The Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation. It has a staff of approximately 800 and is located at the Lucas Heights Science and Technology Centre, some 40 km south west of Sydney city centre. The science and technology centre occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO operates Australia’s only nuclear reactor, the research reactor HIFAR (which stands for High Flux Australian Reactor). The reactor is used to produce radioactive products for use in medicine and industry. It is also used extensively as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. The facility is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, an inner west suburb of Sydney. ANSTO provides the broad range of technical expertise needed to support Australia’s nuclear interests. It advises the Commonwealth Government on issues associated with the nuclear fuel cycle and the operation of nuclear facilities and it supports industry through the development and application of nuclear science based technology and associated capabilities. ANSTO organises its activities under six core business areas. Safety and environmental protection arrangements at ANSTO facilities are reported against separately. Further information about the organisation is available on ANSTO’s web site at www.ansto.gov.au.
- ItemANSTO annual report 2001-02(Australian Nuclear Science and Technology Organisation, 2002) Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. This is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, close to Sydney’s central business district. ANSTO has a salaried staff of approximately 850. Its main site is located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district. The LHSTC occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2002-03(Australian Nuclear Science and Technology Organisation, 2003) Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development (R&D) organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron (NMC), an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2003-04(Australian Nuclear Science and Technology Organisation, 2004)The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor, HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2005-06(Australian Nuclear Science and Technology Organisation, 2006) The Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its commissioning phase. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2006-07(Australian Nuclear Science and Technology Organisation, 2007) The Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 950 staff, ANSTO is responsible for delivering specialised advice, scientific services and products togovernment, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the Open Pool Australian Light-water reactor (OPAL), Australia’s new $470 million research reactor, particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. OPAL is Australia’s only operating nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The High Flux Australian Reactor (HIFAR), which was Australia’s first reactor, was officially shut down in January 2007 and is currently awaiting decommissioning. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The Organisation’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2007-08(Australian Nuclear Science and Technology Organisation, 2008) Australian Nuclear Science and Technology OrganisationThe Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. ANSTO operates Australia’s nuclear research reactor OPAL. OPAL is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s nuclear infrastructure also includes particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. ANSTO’s main site is located 40 kilometres south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 kilometre buffer zone. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. The cyclotron is situated at the Royal Prince Alfred Hospital in Camperdown, Sydney. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through corporate drivers of vision, mission and strategic goals.
- ItemANSTO annual report 2008-09(Australian Nuclear Science and Technology Organisation, 2009) Australian Nuclear Science and Technology OrganisationANSTO is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO undertakes research in the applications of nuclear science and technology and delivers specialised advice, scientific services and products to government, universities, other research organisations, international organisations and businesses in areas as diverse as mining and radiopharmaceuticals. About one-third of ANSTO’s staff are involved in research. The balance are in business services, operations and support to government roles. ANSTO operates Australia’s nuclear research reactor OPAL which is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s research infrastructure also includes accelerators, cyclotrons and associated instruments as well as workshops, pilot plants and specialist laboratories. ANSTO’s research infrastructure is used extensively by other members of the Australian and international research communities including researchers from universities, other science and technology organisations and industry. ANSTO also manages the Access to Major Research Facilities Program (AMRFP), which provides Australian researchers with access to major international facilities. ANSTO’s main campus is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through its strategic and annual planning process.
- ItemANSTO annual report 2009-10(Australian Nuclear Science and Technology Organisation, 2010-10) Australian Nuclear Science and Technology OrganisationANSTO is Australia’s national nuclear science and technology organisation and represents a concentration of Australia’s best nuclear science capabilities. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO provides policy advice to the Australian Government in relation to all matters within the ambit of nuclear science and technology. In addition, ANSTO maintains critical capabilities to support government in undertaking its regional and international role and obligations in relation to nuclear science and technology. Research and innovation are central to ANSTO’s mission and mandate. Key outcomes include: research publications; the securing of intellectual property; training of research students; software development; engineering designs and demonstrators and engineering services; pilot plants and industrial consultancy for clients. We also license technology that arises from our innovation activities. ANSTO provides local and global partners with access to its research and innovation infrastructure to leverage their own research and innovation activities. This collaboration considerably expands the opportunity for the development of locally and globally significant research that will benefit all. ANSTO manufactures products and provides specialised services for customers. These commercial activities draw on ANSTO’s scientists and engineers to develop new products and manufacturing approaches and enhance product quality. Our businesses are focussed on the health of Australians, particularly in the application of radioisotopes for imaging and therapy; the application of mineral processing for naturally occurring radioactive materials; safe treatment and disposition of nuclear waste; and specialised irradiation services. ANSTO is the custodian of landmark infrastructure deployed in the national interest. ANSTO operates Australia’s OPAL multipurpose research reactor. Research reactors are essentially ‘neutron factories’. The neutrons are used for scientific research, the production of radioisotopes used in medicine, activating targets (such as mineral samples for research) and modifying the conductivity of single crystal silicon used for microelectonics. Complementing the OPAL reactor are particle accelerators which are part of the essential toolkit used for precisely dating geological samples, studying the history of climate variability, and materials research, among other applications. ANSTO is a leader in pilot plant design, operation and management for the mining industry. These plants are a significant factor in transferring laboratory results to industry and providing industry with greater confidence prior to full-scale plant development.
- ItemANSTO annual report 2010-2011(Australian Nuclear Science and Technology Organisation, 2011-10-05) Australian Nuclear Science and Technology OrganisationANSTO – the Australian Nuclear Science and Technology Organisation – is home to Australia’s nuclear expertise. ANSTO employs over 1,100 people in southwest Sydney, and supplies Australia with outstanding nuclear research, medicine and technology capabilities. The organisation provides policy advice to Government on all matters relating to nuclear science, technology and engineering. It supports Government in undertaking its international roles and obligations. It also undertakes research and pursues innovation in areas aligned with the national research priorities and those that have the potential to deliver key outcomes to support Australians and Australian industry. ANSTO strives to achieve key outcomes in publishing scientific research, securing intellectual property, training research students, developing software, providing engineering design and services, and consulting for industry. Innovation is critical to increasing Australia’s productivity and competitiveness. The Australian Government invested over $9 billion in science research and innovation in the 2010-2011 financial year and this investment is evident through the landmark science infrastructure Australian scientists can now access at ANSTO.